| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 7.5× | −1.7× | |
| Price / Book | −16.7× | 2.0× | |
| Price / Sales | 2.3× | 4.0× | |
| Price / Free cash flow | 6.1× | −1.6× | |
| EV / EBITDA | 6.7× | −1.2× | |
| Earnings yield | 13.3% | −14.6% | |
| Free cash flow yield | 16.4% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLY |
| $1,250.02 |
| −0.56% |
| $1.18T |
| 57.3× |
| 77.8% |
| +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $254.26 | −0.51% | $612.74B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $284.28 | −0.40% | $502.36B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $405.22 | +0.94% | $363.72B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.26 | −1.16% | $355.91B | 19.7× | 34.7% | +73.5% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.52 | −0.07% | $278.45B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $164.57 | −0.51% | $255.23B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $680.44 | −1.39% | $251.59B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $428.45 | −0.93% | $231.63B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.46 | −1.11% | $191.52B | 22.8× | 37.5% | +32.0% |
